Concepedia

Publication | Open Access

Thrombospondin 2 is a key determinant of fibrogenesis in non‐alcoholic fatty liver disease

DOIFull Paper Access

15

Citations

31

References

2023

Year

Takefumi Kimura, Takanobu Iwadare, Shun‐ichi Wakabayashi, Seema Kuldeep, Tomoyuki Nakajima, Tomoo Yamazaki, Daiki Aomura, Hamim Zafar, Mai Iwaya, Satoru Joshita,
Liver International

Abstract

THBS2/TSP2 is highly expressed in HSCs and plays a role in regulating fibrogenesis in NAFLD patients. THBS2/TSP2 may therefore represent a potential target for anti-fibrotic therapy in NAFLD.

References

YearCitations

Page 1